PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Rating of “Hold” by Analysts

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has been assigned a consensus recommendation of “Hold” from the sixteen analysts that are presently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a sell rating, six have given a hold rating, six have assigned a buy rating and one has given […]

Leave a Reply

Your email address will not be published.

Previous post Head to Head Analysis: Burke & Herbert Financial Services (NASDAQ:BHRB) vs. First Bancshares (NASDAQ:FBMS)
Next post Financial Contrast: Grafton Group (OTCMKTS:GROUF) versus DXP Enterprises (NASDAQ:DXPE)